CFAP298

Across TCGA pan-cancer cohorts, CFAP298 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CFAP298’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where CFAP298 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CFAP298 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

BLCA, KICH, and COAD are the cancer types where CFAP298 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CFAP298 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	All	+1.034	<.001	11	view →
KICH	Female	II,III,IV	−1.861	<.001	10	view →
COAD	Male	II,III,IV	+0.864	<.001	10	view →
LIHC	Female	II,III,IV	+0.850	<.001	9	view →
STAD	All	III,IV	+0.794	<.001	9	view →
BRCA	All	III,IV	+0.673	<.001	6	view →
CHOL	Male	All	+1.906	<.001	5	view →
ESCA	All	All	+0.701	.001	4	view →
HNSC	Male	III,IV	+0.450	.004	4	view →
READ	All	All	+0.705	.002	2	view →
PRAD	All	All	+0.246	<.001	2	view →
KIRC	Female	IV	+0.360	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CFAP298–BLCA

Open the BLCA breakdown →